Role of monoamine transporters in mediating psychostimulant effects
about
A practical guide to the therapy of narcolepsy and hypersomnia syndromesVesicular monoamine transporter 2: role as a novel target for drug developmentFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansGreater ethanol-induced locomotor activation in DBA/2J versus C57BL/6J mice is not predicted by presynaptic striatal dopamine dynamicsReward processing in autism: a thematic series.Discriminative stimulus effects of cocaine and amphetamine in rats following developmental exposure to polychlorinated biphenyls (PCBs).Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in miceSingle and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in ratsThe vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2.Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatumSyntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.Cytoplasmic permeation pathway of neurotransmitter transporters.Reinforcing effects of methamphetamine in an animal model of attention-deficit/hyperactivity disorder--the spontaneously hypertensive ratDrug addiction.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.Attention enhancing effects of methylphenidate are age-dependent.Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.Pathway-specific engagement of ephrinA5-EphA4/EphA5 system of the substantia nigra pars reticulata in cocaine-induced responsesAdolescent social defeat alters markers of adult dopaminergic function.Preclinical evaluation of the abuse potential of the analgesic bicifadine.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.Structure of distress call: implication for specificity and activation of dopaminergic system.Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons.Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDSThe human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.Stimulation-evoked dopamine release in the nucleus accumbens following cocaine administration in rats perinatally exposed to polychlorinated biphenyls.Circuits Regulating Pleasure and Happiness-Mechanisms of Depression.A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1ALipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kBUnique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine.Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.
P2860
Q24623713-B3AD4EC2-4957-4A0D-93DF-E5DAE69EBABDQ24647764-CA36B942-70B3-4DE5-950A-5BB3F57C365BQ24654140-A1354BF9-3F20-4C4A-900C-43A4498F301CQ28537646-BFB3243C-B7F6-46E6-8DBC-341B63854C4EQ30462673-CB8AE7AB-6CDF-494B-8986-809097E35C80Q30498363-44EA16E7-1CEB-4FC6-BDB9-5D3706B65D95Q30523813-9FAC0BDC-A2F9-48B0-AA37-70405F4E6C1DQ33580523-EBB97257-08E9-47EB-BC5A-700BF28BDFD1Q33738102-51D0254F-156B-48AF-A379-DC39771F0A6AQ33748306-6B2CDF71-C311-469D-9A8E-4C6E7EEF8980Q33854736-E8F05EC4-CE04-48AA-B7CF-3E9276669E0CQ33905809-3AF5E546-7BB0-4C86-91EC-C86910D87920Q34042123-258814DE-681B-4F93-92C4-87BF5AD4AD1EQ34051713-BEB38B90-C90C-4284-B5C0-4AD01805C781Q34103973-B553FFE5-49A9-4B47-AFBE-66FB9EBDCF47Q34202128-0D7DCD82-5463-4BE9-BCC2-27489B276675Q34468086-849347E3-95A9-4338-8749-C8E792D34DDBQ34575484-ED0B844A-681C-4D5D-B86F-46022286F445Q34673305-BB2426B7-F444-4A57-9EC3-FDD364122FC9Q34900437-49689ADD-EDB5-4206-B0C8-D4FD85BB923EQ34902438-7C8C3321-05DF-452A-9A1E-F874655206A9Q34986560-60CB2699-ED6E-4658-BFDD-6062602C6B46Q35049129-ED18B3B3-641B-4EF2-8DFB-AD39EAB7F38BQ35166300-7EFF6271-894D-4090-AB96-3E16FDB368A8Q35453895-1E144C4A-B94E-4445-9372-BCB1F1AE6FB1Q35532072-E139CF49-88AD-43D5-955F-F9758303E247Q35669953-87F7B3B3-DB5E-4EF3-B919-2BB23D4F5BECQ35853641-13797FED-ED74-4F8F-B938-532EF65683C8Q35913066-33296062-D2BB-4664-BF1A-154BFE41ACEBQ36062432-CB3AEB70-840E-49D6-92A9-7C54C0AB8407Q36323546-09EB814A-747B-4B90-9565-7FC697D3C37FQ36337087-E86A6485-E0F9-4C81-BB77-FF9072E73A23Q36856162-2FA3724B-C2A4-4153-A557-DA06556B6CE2Q37275623-8E521166-91C2-4394-9540-E6206680C9A8Q37312631-72B61858-5165-40EC-874E-AF6C28896223Q37405040-C9E61326-98AF-43F6-98E3-E5B99BC51DE1Q37432159-8FD023AC-B814-42E6-9E23-9852A6EEDA17Q37446868-25E90954-9B7D-4A99-9C51-B5D10E4BDBBBQ37533318-C669D78B-B297-42B8-9F1A-6872393A1A87Q37661270-04A90686-AA43-41F6-BC42-65DCCD7ECD23
P2860
Role of monoamine transporters in mediating psychostimulant effects
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Role of monoamine transporters in mediating psychostimulant effects
@ast
Role of monoamine transporters in mediating psychostimulant effects
@en
Role of monoamine transporters in mediating psychostimulant effects
@nl
type
label
Role of monoamine transporters in mediating psychostimulant effects
@ast
Role of monoamine transporters in mediating psychostimulant effects
@en
Role of monoamine transporters in mediating psychostimulant effects
@nl
prefLabel
Role of monoamine transporters in mediating psychostimulant effects
@ast
Role of monoamine transporters in mediating psychostimulant effects
@en
Role of monoamine transporters in mediating psychostimulant effects
@nl
P2093
P2860
P3181
P356
P1433
P1476
Role of monoamine transporters in mediating psychostimulant effects
@en
P2093
Annette E Fleckenstein
Evan L Riddle
Glen R Hanson
P2860
P2888
P304
P3181
P356
10.1208/AAPSJ070481
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1033527981